ADHD Symptoms and Medical Cannabis Use Among Adults With Chronic Pain
Journal of Attention Disorders · 2025
DOI: 10.1177/10870547251336841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, 2025. Verfasst von David Saunders und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Chronic Pain, Medical Marijuana, Attention Deficit Disorder with Hyperactivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCCIH NIH HHS, NCATS NIH HHS.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Objective
We examined whether medical cannabis (MC) use was associated with change in ADHD symptoms across time in a sample of adults with chronic pain.
Methods
We conducted a longitudinal cohort study ( N = 223) across 12 months, assessing ADHD symptoms and MC use. We used mixed-effects linear regression to test whether MC use (vs. no use) and high THC (vs. low THC) MC was associated with change in ADHD symptoms from baseline to follow-up at quarterly intervals. We stratified by baseline ADHD symptoms and pain catastrophizing.
Results
MC use was not associated with change in ADHD symptoms in the full sample or those with moderate/severe ADHD symptoms. Among those with minor/no baseline ADHD symptoms, high-THC MC (vs. low-THC) was associated with a decrease in ADHD symptoms.
Conclusions
The null findings among participants with moderate/severe ADHD symptoms suggests that cannabis is unlikely to be a good treatment for ADHD. The preliminary findings in those with mild ADHD symptoms should be interpreted with caution given the small sample, the modest result, and all participants had chronic pain. These results may temper enthusiasm for MC as a treatment for ADHD, but further studies in larger and more generalizable samples may be justified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
- Division of Child Psychiatry, New York State Psychiatric Institute, USA.
- Division of General Internal Medicine, Montefiore Health System, Bronx, NY, USA.
- Albert Einstein College of Medicine, General Internal Medicine, Bronx, NY, USA.
- CUNY School of Medicine at The City College of New York, USA.
- Department of Psychology, Fordham University, Bronx, NY, USA.
ORCID-Profile: David Saunders, Frances Levin
Förderung
- NIDA NIH HHS
- NCCIH NIH HHS
- NCATS NIH HHS
- NIAID NIH HHS
- Einstein-Rockefeller-CUNY Center for AIDS Research, Albert Einstein College of Medicine
- National Center for Advancing Translational Sciences
- National Institute on Drug Abuse
Zitieren
APA
Saunders, D., Slawek, D., Zhang, C., Sohler, N., Cunningham, C., Minami, H., Starrels, J., Arnsten, J., & Levin, F. (2025). ADHD Symptoms and Medical Cannabis Use Among Adults With Chronic Pain. Journal of Attention Disorders. https://doi.org/10.1177/10870547251336841
Vancouver
Saunders D, Slawek D, Zhang C, Sohler N, Cunningham C, Minami H, et al. ADHD Symptoms and Medical Cannabis Use Among Adults With Chronic Pain. Journal of Attention Disorders. 2025. doi:10.1177/10870547251336841
BibTeX
@article{Saunders2025,
author = {Saunders, David and Slawek, Deepika and Zhang, Chenshu and Sohler, Nancy and Cunningham, Chinazo and Minami, Haruka and Starrels, Joanna and Arnsten, Julia and Levin, Frances},
title = {ADHD Symptoms and Medical Cannabis Use Among Adults With Chronic Pain},
journal = {Journal of Attention Disorders},
year = {2025},
doi = {10.1177/10870547251336841}
}
EUVIMED